These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37928542)

  • 1. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
    Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
    Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
    Yew PY; Alachkar H; Yamaguchi R; Kiyotani K; Fang H; Yap KL; Liu HT; Wickrema A; Artz A; van Besien K; Imoto S; Miyano S; Bishop MR; Stock W; Nakamura Y
    Bone Marrow Transplant; 2015 Sep; 50(9):1227-34. PubMed ID: 26052909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Whole CDR3 T Cell Receptor Repertoire after Hematopoietic Stem Cell Transplantation in 2 Clinical Cohorts.
    Shah O; Tamaresis JS; Kenyon LJ; Xu L; Zheng P; Gupta P; Rangarajan K; Lee S; Spellman S; Nikiforow S; Zehnder J; Meyer EH
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1050-1070. PubMed ID: 32081787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.
    Calviño C; Ceballos C; Alfonso A; Jauregui P; Calleja-Cervantes ME; San Martin-Uriz P; Rodriguez-Marquez P; Martin-Mallo A; Iglesias E; Abizanda G; Rodriguez-Diaz S; Martinez-Turrillas R; Illarramendi J; Viguria MC; Redondo M; Rifon J; Villar S; Lasarte JJ; Inoges S; Lopez-Diaz de Cerio A; Hernaez M; Prosper F; Rodriguez-Madoz JR
    Front Immunol; 2023; 14():1270843. PubMed ID: 37795087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
    Wu Y; Fu J; Wang H; Yu XZ
    Front Immunol; 2021; 12():778996. PubMed ID: 34950143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA methylation landscape across the TCR loci in patients with acute myeloid leukemia.
    Pospiech M; Beckford J; Kumar AMS; Tamizharasan M; Brito J; Liang G; Mangul S; Alachkar H
    Int Immunopharmacol; 2024 Sep; 138():112376. PubMed ID: 38917523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML.
    Lo Presti V; Meringa A; Dunnebach E; van Velzen A; Moreira AV; Stam RW; Kotecha RS; Krippner-Heidenreich A; Heidenreich OT; Plantinga M; Cornel A; Sebestyen Z; Kuball J; van Til NP; Nierkens S
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma.
    van Amerongen RA; Hagedoorn RS; Remst DFG; Assendelft DC; van der Steen DM; Wouters AK; van de Meent M; Kester MGD; de Ru AH; Griffioen M; van Veelen PA; Falkenburg JHF; Heemskerk MHM
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep-sequencing of the T-cell receptor repertoire in patients with haplo-cord and matched-donor transplants.
    Alachkar H; Nakamura Y
    Chimerism; 2015 Jul; 6(3):47-9. PubMed ID: 26745665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function.
    Ruggiero E; Carnevale E; Prodeus A; Magnani ZI; Camisa B; Merelli I; Politano C; Stasi L; Potenza A; Cianciotti BC; Manfredi F; Di Bono M; Vago L; Tassara M; Mastaglio S; Ponzoni M; Sanvito F; Liu D; Balwani I; Galli R; Genua M; Ostuni R; Doglio M; O'Connell D; Dutta I; Yazinski SA; McKee M; Arredouani MS; Schultes B; Ciceri F; Bonini C
    Sci Transl Med; 2022 Feb; 14(631):eabg8027. PubMed ID: 35138911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.
    Noviello M; Manfredi F; Ruggiero E; Perini T; Oliveira G; Cortesi F; De Simone P; Toffalori C; Gambacorta V; Greco R; Peccatori J; Casucci M; Casorati G; Dellabona P; Onozawa M; Teshima T; Griffioen M; Halkes CJM; Falkenburg JHF; Stölzel F; Altmann H; Bornhäuser M; Waterhouse M; Zeiser R; Finke J; Cieri N; Bondanza A; Vago L; Ciceri F; Bonini C
    Nat Commun; 2019 Mar; 10(1):1065. PubMed ID: 30911002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
    Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
    Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed.
    Gielis S; Flumens D; van der Heijden S; Versteven M; De Reu H; Bartholomeus E; Schippers J; Campillo-Davo D; Berneman ZN; Anguille S; Smits E; Ogunjimi B; Lion E; Laukens K; Meysman P
    Ann Hematol; 2024 Sep; ():. PubMed ID: 39259326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.
    Tawara I; Kageyama S; Miyahara Y; Fujiwara H; Nishida T; Akatsuka Y; Ikeda H; Tanimoto K; Terakura S; Murata M; Inaguma Y; Masuya M; Inoue N; Kidokoro T; Okamoto S; Tomura D; Chono H; Nukaya I; Mineno J; Naoe T; Emi N; Yasukawa M; Katayama N; Shiku H
    Blood; 2017 Nov; 130(18):1985-1994. PubMed ID: 28860210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.
    Link CS; Eugster A; Heidenreich F; Rücker-Braun E; Schmiedgen M; Oelschlägel U; Kühn D; Dietz S; Fuchs Y; Dahl A; Domingues AM; Klesse C; Schmitz M; Ehninger G; Bornhäuser M; Schetelig J; Bonifacio E
    Clin Exp Immunol; 2016 Jun; 184(3):389-402. PubMed ID: 26800118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity.
    Jahn B; Bergmann L; Weidmann E; Brieger J; Fenchel K; Schwulera U; Hoelzer D; Mitrou PS
    Leuk Res; 1995 Feb; 19(2):73-82. PubMed ID: 7869744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft γδ TCR Sequencing Identifies Public Clonotypes Associated with Hematopoietic Stem Cell Transplantation Efficacy in Acute Myeloid Leukemia Patients and Unravels Cytomegalovirus Impact on Repertoire Distribution.
    Arruda LCM; Gaballa A; Uhlin M
    J Immunol; 2019 Mar; 202(6):1859-1870. PubMed ID: 30710048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Wilms Tumor Protein 1" (WT1) peptide vaccination-induced complete remission in a patient with acute myeloid leukemia is accompanied by the emergence of a predominant T-cell clone both in blood and bone marrow.
    Ochsenreither S; Fusi A; Busse A; Bauer S; Scheibenbogen C; Stather D; Thiel E; Keilholz U; Letsch A
    J Immunother; 2011 Jan; 34(1):85-91. PubMed ID: 21150716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
    Abbas HA; Hao D; Tomczak K; Barrodia P; Im JS; Reville PK; Alaniz Z; Wang W; Wang R; Wang F; Al-Atrash G; Takahashi K; Ning J; Ding M; Beird HC; Mathews JT; Little L; Zhang J; Basu S; Konopleva M; Marques-Piubelli ML; Solis LM; Parra ER; Lu W; Tamegnon A; Garcia-Manero G; Green MR; Sharma P; Allison JP; Kornblau SM; Rai K; Wang L; Daver N; Futreal A
    Nat Commun; 2021 Oct; 12(1):6071. PubMed ID: 34663807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant.
    Chapuis AG; Egan DN; Bar M; Schmitt TM; McAfee MS; Paulson KG; Voillet V; Gottardo R; Ragnarsson GB; Bleakley M; Yeung CC; Muhlhauser P; Nguyen HN; Kropp LA; Castelli L; Wagener F; Hunter D; Lindberg M; Cohen K; Seese A; McElrath MJ; Duerkopp N; Gooley TA; Greenberg PD
    Nat Med; 2019 Jul; 25(7):1064-1072. PubMed ID: 31235963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.